Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis

Nutritional Assessments by Bioimpedance Technique in Dialysis Patients

Bioelectrical impedance analysis (BIA) has been extensively applied in nutritional assessments on the general population, and it is recommended in establishing the diagnosis of malnutrition and sarcopenia. The bioimpedance technique has become a promising modality through which to measure the whole-body composition in dialysis patients, where the presence of subclinical volume overload and sarcopenic obesity may be overlooked by assessing body weight alone. In the past two decades, bioimpedance devices have evolved from applying a single frequency to a range of frequencies (bioimpedance spectroscopy, BIS), in which the latter is incorporated with a three-compartment model that allows for the simultaneous measurement of the volume of overhydration, adipose tissue mass (ATM), and lean tissue mass (LTM). However, clinicians should be aware of common potential limitations, such as the adoption of population-specific prediction equations in some BIA devices. Inherent prediction error does exist in the bioimpedance technique, but the extent to which this error becomes clinically significant remains to be determined. Importantly, reduction in LTM has been associated with increased risk of frailty, hospitalization, and mortality in dialysis patients, whereas the prognostic value of ATM remains debatable. Further studies are needed to determine whether modifications of bioimpedance-derived body composition parameters through nutrition intervention can result in clinical benefits.

Differences in bioimpedance-derived fluid status between two versions of the Body Composition Monitor

OBJECTIVES

The Body Composition Monitor (BCM) (Fresenius Medical Care) measures body impedances in alternating currents to subsequently calculate fat and lean tissue mass, fluid compartments, and overhydration (OH). The aim of this study was to investigate differences between two versions of the BCM (an older version, 3.2.5, and a newer version, 3.3.3).

METHODS

Between September 2021 and December 2021, 28 hemodialysis patients were included to undergo BCM measurements before each of 14 consecutive dialysis sessions with versions 3.2.5 and 3.3.3 devices. Measurements were performed according to instructions provided by the manufacturer. Differences between BCM devices were tested for statistical significance using paired Wilcoxon tests, neglecting clustering.

RESULTS

A total of 288 measurement pairs of 27 patients were left after exclusion of 43 flawed data points. The mean difference in OH between both BCM devices was 0.548 L (higher for version 3.2.5). Analysis of impedance data revealed differences in the high-frequency spectrum, quantifiable by the intracellular resistance, Ri (median Ri version 3.2.5 = 1750.3 Ω; Ri version 3.3.3 = 1612.45 Ω; P < 0.001), and the time delay, Td (median Td version 3.2.5 = 1.85 ns; Td version 3.3.3 = 8.88 nanoseconds; P < 0.001).

CONCLUSIONS

This study finds that results between the two versions of the BCM differed in a clinically meaningful fashion and that the newer version 3.3.3 device had a bias toward less OH. Circulating BCM devices should be checked for versions and only devices of the same version should be used for each patient to ensure better within-patient consistency.

A scoping review of the methods used in patients with liver cirrhosis to assess body composition and their nutritional findings

BACKGROUND AND OBJECTIVES

Body composition (BC) assessment in cirrhosis has a wide variety of methods with no consensus on the best tools for each body component in patients with Liver Cirrhosis (LC). We aimed to conduct a systematic scoping review of the most frequent body composition analysis methods and nutritional findings published in liver cirrhosis patients.

METHODS

We searched for articles in PubMed, Scopus, and ISI Web of Science databases. Keywords selected the BC methods and parameters in LC.

RESULTS

Eleven methods were found. The most frequently used were computed tomography (CT) 47.5%, Bioimpedance Analysis 35%, DXA 32.5%, and anthropometry 32.5%. Up to 15 BC parameters were reported from each method.

CONCLUSIONS

The vast heterogeneity in the results found during the qualitative analysis and imaging methods must reach a consensus to achieve a better clinical practice and improve nutritional treatment, as the physiopathology in LC compromises the nutritional status directly.

Evaluating Research Grade Bioimpedance Hardware Using Textile Electrodes for Long-Term Fluid Status Monitoring

Fluid overload is a chronic medical condition that affects over six million Americans with conditions such as congestive heart failure, end-stage renal disease, and lymphedema. Remote management of fluid overload continues to be a leading clinical challenge. Bioimpedance is one technique that can be used to estimate the hydration of tissue and track it over time. However, commercially available bioimpedance measurement systems are bulky, expensive, and rely on Ag/AgCl electrodes that dry out and can irritate the skin. The use of bioimpedance today is therefore limited to clinical and research settings, with measurements performed at daily intervals or over short periods of time rather than continuously and long-term. This paper proposes using wearable calf bioimpedance measurements integrated into a compression sock for long-term fluid overload management. A PCB was developed using standard measurement techniques that measures the calf bioimpedance using a custom analog front-end built around an AD8302 gain-phase detection chip. Data is transmitted wirelessly via Bluetooth Low Energy to an iOS device using a custom iOS app. Bioimpedance data were collected both from the wearable system and a commercial measurement system (ImpediMed SFB7) using RRC networks, Ag/AgCl electrodes, and the textile compression sock. Bioimpedance data collected from the wearable system showed close agreement with data from the SFB7 when using RRC networks and in five healthy human subjects with Ag/AgCl electrodes. However, when using the textile compression sock the wearable system had worse precision than the SFB7 (4% run to run compared to <1% run to run) and there were larger differences between the two systems than when using the RRC networks and the Ag/AgCl electrodes. Wearable system precision and agreement with the SFB7 was improved by pressure or light wetting of the current electrodes on the sock. Future research should focus on reliable elimination of low-frequency artifacts in research grade hardware to enable long-term calf bioimpedance measurements for fluid overload management.